{"favorite_id": 2024, "calc_type": "calculator", "dosing": false, "full_title_en": "Lille Model for Alcoholic Hepatitis", "short_title_en": "Lille Model", "medium_description_en": "Predicts mortality in patients with Alcoholic Hepatitis not responding to steroid therapy.", "short_description_en": "Mortality in Alcoholic Hepatitis that's unresponsive to steroids.", "before_use": "", "instructions_en": "The Lille Model risk stratifies patients already receiving steroids for alcoholic hepatitis treatment for 7 days to predict which will not improve and should be considered for other management strategies. All values besides 7-day bilirubin are taken from admission.", "purpose_en": ["Prognosis", "Treatment"], "disease_en": ["Alcoholism", "Cirrhosis", "Hepatitis"], "specialty_en": ["Critical Care", "Gastroenterology", "Hepatology", "Hospitalist Medicine", "Internal Medicine", "Toxicology"], "chief_complaint_en": ["Abdominal Pain", "Intoxication/Overdose"], "system_en": ["Gastrointestinal"], "search_abbreviation_en": ["Lille", "Alcoholic", "Hepatitis"], "slug": "lille-model-alcoholic-hepatitis", "seo": {"meta_description_en": "The Lille Model for Alcoholic Hepatitis predicts mortality in patients with Alcoholic Hepatitis not responding to steroid therapy.", "keywords_en": "Lille model, Lille calculator, lille hepatitis, alcoholism score, alcoholic hepatitis model, lille calc, lille hep calc, lille hep calculator, lille hep score, lille hep model, lille alcoholic hep, lille alcoholic hepatitis model, lille mode for alcoholic hepatitis, lille discriminant function, lille corticosteroid, corticosteroid therapy model, steroid therapy for hepatitis, steroid therapy for alcoholic hepatitis"}, "content": {"how_to_use": {"use_case_en": "<p>Identification of patients with alcoholic hepatitis not responding to steroids who should be considered for alternative therapies or early referral for transplant.</p>", "pearls_pitfalls_en": "", "why_use_en": ""}, "next_steps": {"advice_en": "<p>It is known that not all patients with alcoholic hepatitis will respond to steroids, but was not previously known which of the non-responders would have a poor prognosis; the Lille Model helps determine this.</p>", "management_en": "", "critical_actions_en": ""}, "about": {"formula_en": "<p>Lille Model Score = (exp(-R))/(1 + exp(-R))</p>\n<p>where the variables are as follows:</p>\n<p>R = 3.19 &ndash; 0.101*(age, years) + 0.147*(albumin day 0, g/L) + 0.0165* (evolution in bilirubin level, &micro;mol/L) - 0.206*(renal insufficiency) - 0.0065*(bilirubin day 0, &micro;mol/L) - 0.0096*(PT, sec)</p>\n<p>Renal insufficiency = 1 (if Cr &gt;1.3 mg/dL (115&nbsp;&micro;mol/L)) or 0 (if &le;1.3 mg/dL (115&nbsp;&micro;mol/L))</p>\n<p></p>\n<p></p>", "more_info_en": "<p>The Lille Model predicts mortality rates within 6 months.</p> <ul> <li>Scores &gt;0.45 predict a 6-month survival of 25%.</li> <li>Scores &lt;0.45 predict a 6-month survival of 85%.</li> </ul>", "evidence_based_medicine_en": "", "references_list": {"Original/Primary Reference": [{"href": "http://www.ncbi.nlm.nih.gov/pubmed/17518367", "text": "Louvet A, Naveau S, Abdelnour M, Ramond MJ, Diaz E, Fartoux L, Dharancy S, Texier F, Hollebecque A, Serfaty L, Boleslawski E, Deltenre P, Canva V, Pruvot FR, Mathurin P. The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids. Hepatology. 2007; 45(6):1348-54."}], "Other References": [{"href": "", "text": ""}], "Validation": [{"href": "http://www.ncbi.nlm.nih.gov/pubmed/21591871", "text": "Sandahl TD, Jepsen P, Ott P, Vilstrup H.Validation of prognostic scores for clinical use in patients with alcoholic hepatitis. Scand J Gastroenterol. 2011; 46(9):1127-32. doi: 10.3109/00365521.2011.587200. Epub 2011 May 18."}], "Clinical Practice Guidelines": [{"href": "", "text": ""}], "Manufacturer Website": [{"href": "", "text": ""}], "Outcomes": [{"href": "", "text": ""}]}}, "contributor": {"expert_name": []}, "reviewer": {"expert_name": []}, "creator": [{"name": "Dr. Philippe Mathurin", "creator_info": {"about_en": "<p>Philippe Mathurin, MD, PhD, is professor of hepatology and head of the research program on liver disease in the Department of Hepatology and Gastroenterology at the University Hospital of Lille, France. He has been an associate editor of the Journal of Hepatology since 2009. Dr. Mathurin has published extensively on research topics including alcoholic liver disease, viral hepatitis, non alcoholic fatty liver disease and hepatocellular carcinoma.</p>", "photo_en": "https://cdn-web-img.mdcalc.com/people/dr-philippe-mathurin.jpeg", "pubmedLink": "http://www.ncbi.nlm.nih.gov/pubmed/?term=Mathurin+P%5BAuthor%5D"}}], "related_resources": {"mdcalc_rating": {"evidence": "", "clinical": "", "popularity": ""}, "guidelines": [], "teaching": [], "videos": [], "interests": [], "partner_contact": [], "sdm_tool": []}}, "input_schema": [{"type": "textbox", "label_en": "Age", "name": "age", "unit": "age", "conditionality": "", "optional": false, "unit_info": {"name": "Age", "conversion": 1, "error_min": 0.001, "error_max": 120, "warn_min": 0.1, "warn_max": 100, "normal_max_si": 0, "normal_min_si": 0, "normal_min_us": 0, "units_si": "years", "units_us": "years"}}, {"type": "textbox", "label_en": "Albumin", "name": "alb", "unit": "alb", "conditionality": "", "optional": false, "unit_info": {"name": "Albumin", "conversion": 10, "error_min": 0, "error_max": 7, "warn_min": 1, "warn_max": 6, "normal_max_si": 55, "normal_min_si": 35, "normal_min_us": 3.5, "units_si": "g/L", "units_us": "g/dL", "normal_max_us": 5.5}}, {"type": "textbox", "label_en": "Bilirubin (initial)", "name": "bili_init", "unit": "bili", "conditionality": "", "optional": false, "unit_info": {"name": "Bilirubin", "conversion": 17.104, "error_min": 1e-08, "error_max": 50, "warn_min": 0, "warn_max": 20, "normal_max_si": 32.49, "normal_min_si": 5.13, "normal_min_us": 0.3, "units_si": "\u00b5mol/L", "units_us": "mg/dL", "normal_max_us": 1.9}}, {"type": "textbox", "label_en": "Bilirubin (day 7)", "name": "bili7", "unit": "bili", "conditionality": "", "optional": false, "unit_info": {"name": "Bilirubin", "conversion": 17.104, "error_min": 1e-08, "error_max": 50, "warn_min": 0, "warn_max": 20, "normal_max_si": 32.49, "normal_min_si": 5.13, "normal_min_us": 0.3, "units_si": "\u00b5mol/L", "units_us": "mg/dL", "normal_max_us": 1.9}}, {"type": "textbox", "label_en": "Creatinine", "name": "cr", "unit": "cr", "conditionality": "", "optional": false, "unit_info": {"name": "Creatinine", "conversion": 88.4, "error_min": 0.01, "error_max": 40, "warn_min": 0, "warn_max": 10, "normal_max_si": 115, "normal_min_si": 62, "normal_min_us": 0.7, "units_si": "\u00b5mol/L", "units_us": "mg/dL", "normal_max_us": 1.3}}, {"type": "textbox", "label_en": "PT", "name": "pt", "unit": "pt", "conditionality": "", "optional": false, "unit_info": {"name": "PT ", "conversion": 1, "error_min": 8, "error_max": 100, "warn_min": 9, "warn_max": 50, "normal_max_si": 13, "normal_min_si": 11, "normal_min_us": 11, "units_si": "sec", "units_us": "sec", "normal_max_us": 13}}], "md5": "ad30c8201b5742b5339172c961f9011e", "related_calcs": [{"calcId": 10136, "short_title_en": "ABIC Score for Alcoholic Hepatitis", "slug": "abic-score-alcoholic-hepatitis"}, {"calcId": 2693, "short_title_en": "MELD Score (Original)", "slug": "meld-score-original-pre-2016-model-end-stage-liver-disease"}, {"calcId": 78, "short_title_en": "MELD Score (New)", "slug": "meld-score-model-end-stage-liver-disease-12-older"}]}